HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manfred Wiessler Selected Research

DNA Adducts

1/2005Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
10/2004Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer.
2/2002Capillary electrophoresis analysis of DNA adducts as biomarkers for carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manfred Wiessler Research Topics

Disease

14Neoplasms (Cancer)
01/2016 - 04/2002
3Brain Neoplasms (Brain Tumor)
11/2009 - 09/2008
3Prostatic Neoplasms (Prostate Cancer)
11/2009 - 09/2008
2Melanoma (Melanoma, Malignant)
01/2012 - 02/2005
2Breast Neoplasms (Breast Cancer)
01/2011 - 09/2010
2Glioblastoma (Glioblastoma Multiforme)
02/2009 - 09/2008
2Glioma (Gliomas)
02/2009 - 09/2008
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2004 - 01/2003
1Neoplasm Metastasis (Metastasis)
01/2012
1Aneuploidy (Aneuploid)
11/2009
1Astrocytoma (Pilocytic Astrocytoma)
02/2009
1Cardiotoxicity
09/2002
1Carcinogenesis
02/2002

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
09/2010 - 09/2002
4Temozolomide (Temodar)FDA LinkGeneric
11/2009 - 09/2008
4aristolochic acid I (aristolochic acid)IBA
01/2005 - 04/2002
3Hormones (Hormone)IBA
11/2009 - 09/2008
3CarcinogensIBA
01/2005 - 04/2002
3DNA AdductsIBA
01/2005 - 02/2002
2Biological ProductsIBA
01/2012 - 06/2004
2DNA (Deoxyribonucleic Acid)IBA
11/2009 - 06/2003
2Cytostatic AgentsIBA
11/2009 - 03/2009
2CytosineIBA
06/2004 - 01/2003
1Coloring Agents (Dyes)IBA
01/2016
1Cathepsin BIBA
01/2012
1furanIBA
01/2012
1Galactose (Galactopyranose)FDA LinkGeneric
01/2012
1HydrogenIBA
01/2012
1OligosaccharidesIBA
01/2012
1Sulfates (Sulfates, Inorganic)IBA
01/2012
1Extracellular Matrix ProteinsIBA
01/2012
1Cysteine Proteases (Cysteine Protease)IBA
01/2012
1IntegrinsIBA
01/2011
1Integrin beta3 (GPIIIa)IBA
09/2010
1GadoliniumIBA
05/2010
1Contrast MediaIBA
05/2010
1FullerenesIBA
05/2010
1Androgen Antagonists (Antiandrogens)IBA
11/2009
1Hydroxyurea (Hydrea)FDA LinkGeneric
02/2005
1GlycoconjugatesIBA
02/2005
1Antineoplastic Agents (Antineoplastics)IBA
02/2005
1Fibronectins (Fibronectin)IBA
02/2005
1CytochromesIBA
01/2005
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
01/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2005
1Proteins (Proteins, Gene)FDA Link
06/2003
1MethyltransferasesIBA
06/2003
1Anti-Bacterial Agents (Antibiotics)IBA
09/2002
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2002
1thiobarbituric acidIBA
09/2002
1Troponin T (Troponin T1)IBA
09/2002
1Daunorubicin (Cerubidine)FDA LinkGeneric
09/2002
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2002
1Alanine Transaminase (SGPT)IBA
09/2002
1ZincIBA
09/2002
1Biomarkers (Surrogate Marker)IBA
02/2002

Therapy/Procedure

5Therapeutics
01/2016 - 06/2003
3Ligation
01/2016 - 02/2009
2Drug Therapy (Chemotherapy)
02/2005 - 09/2002
1Precision Medicine
01/2016
1Combination Drug Therapy (Combination Chemotherapy)
02/2009
1Lasers (Laser)
03/2004